Skip links
Companies
› Ireland › NEOPHARMED GENTILI IRELAND LIMITED

NEOPHARMED GENTILI IRELAND LIMITED

Private limited company (Ltd.) Active

Registration No.
IE636010
Incorporation Date
2018-10-17
Company Type
Private limited company (Ltd.)
Address
HARCOURT ROAD DUBLIN 2, Ireland
Website
www.biocryst.de/
Source: Companies Registration Office (CRO)

NEOPHARMED GENTILI IRELAND LIMITED is a Private limited company (Ltd.) registered in Ireland under IE636010, and its current status with Companies Registration Office (CRO) is active. The company was incorporated on 17 October 2018 and lists its registered address as HARCOURT ROAD DUBLIN 2, Ireland. 1 shareholder is on record for NEOPHARMED GENTILI IRELAND LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies Registration Office (CRO) and was last updated on 24 October 2026.

Data Provenance
This record is sourced directly from official government registries, including Companies Registration Office (CRO).

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

One shareholder is currently on record for NEOPHARMED GENTILI IRELAND LIMITED, held on the Annual Return (Form B1) under section 342 of the Companies Act 2014, which the register supplies only on payment.

The largest of these is BIOCRYST PHARMACEUTICALS INC, holding 100% — a majority holding.

Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
BIOCRYST PHARMACEUTICALS INC 100% Companies Registration Office (CRO)

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Director of NEOPHARMED GENTILI IRELAND LIMITED currently on record is WILLIAM SHERIDAN; five officers are currently on record for NEOPHARMED GENTILI IRELAND LIMITED, filed with Companies Registration Office (CRO).

The register reports 17 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at NEOPHARMED GENTILI IRELAND LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

WS
WILLIAM SHERIDAN ACTIVE

Appointed
2018-10-17
Residence
🇬🇧 United Kingdom
Occupation
Director

PC
PHILIP COLLIS ACTIVE

Appointed
2018-10-17
Residence
🇬🇧 United Kingdom
Occupation
Director

YS
YARLAGADDA SUDHAKARA BABU ACTIVE

Appointed
2018-10-17
Residence
🇬🇧 United Kingdom
Occupation
Director

SA
SYED ABID KARIM ACTIVE

Appointed
2018-10-17
Residence
🇬🇧 United Kingdom
Occupation
Director

CC
CANYON CORPORATE SECRETARIES LIMITED ACTIVE ENTITY

Appointed
2019-01-09
Residence
🇮🇪 Ireland
Occupation
Company Secretary

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

NEOPHARMED GENTILI IRELAND LIMITED sits 6 levels below its ultimate parent, NEONCO SPA, registered in Italy. 7 subsidiaries are recorded beneath it, across 8 jurisdictions. The full chain up to NEONCO SPA is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by NEOPHARMED GENTILI IRELAND LIMITED's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 7 subsidiaries span Ireland, Italy, France, Switzerland, Germany, Austria, and 2 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Ultimate HQ
NEONCO SPA
Italy
BIOCRYST ITALIA SRL
ItalyIT IT12280480968

BIOCRYST FRANCE SAS
FranceFR 89059746100015

BioCryst Schweiz GmbH
SwitzerlandCH CHE-455.845.799

BioCryst Pharma Deutschland GmbH
GermanyDE 80333B259604

BioCryst Pharma Deutschland GmbH
Austria#0412047414

BioCryst Netherlands B.V.
NetherlandsNL 86124641

BIOCRYST ESPAÑA SL.
SpainES B09863655

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on NEOPHARMED GENTILI IRELAND LIMITED?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns NEOPHARMED GENTILI IRELAND LIMITED?

One shareholder is currently on record for NEOPHARMED GENTILI IRELAND LIMITED, held on the Annual Return (Form B1) under section 342 of the Companies Act 2014, which the register supplies only on payment. The largest of these is BIOCRYST PHARMACEUTICALS INC, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is NEOPHARMED GENTILI IRELAND LIMITED's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for NEOPHARMED GENTILI IRELAND LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does NEOPHARMED GENTILI IRELAND LIMITED have on record?

1 shareholder is shown on record for NEOPHARMED GENTILI IRELAND LIMITED.

What is NEOPHARMED GENTILI IRELAND LIMITED's company registration number?

NEOPHARMED GENTILI IRELAND LIMITED's registration number is IE636010, filed with Companies Registration Office (CRO) in Ireland. Its current status on the register is active.

Is NEOPHARMED GENTILI IRELAND LIMITED still an active company?

NEOPHARMED GENTILI IRELAND LIMITED's status on Companies Registration Office (CRO) is listed as active.

When was NEOPHARMED GENTILI IRELAND LIMITED incorporated?

NEOPHARMED GENTILI IRELAND LIMITED was incorporated on 17 October 2018, according to Companies Registration Office (CRO).

What is NEOPHARMED GENTILI IRELAND LIMITED's registered address?

The registered address on file for NEOPHARMED GENTILI IRELAND LIMITED is HARCOURT ROAD DUBLIN 2, Ireland.

What legal structure is NEOPHARMED GENTILI IRELAND LIMITED registered as?

NEOPHARMED GENTILI IRELAND LIMITED is registered as a Private limited company (Ltd.) in Ireland.

Who are the officers/directors of NEOPHARMED GENTILI IRELAND LIMITED?

The Director of NEOPHARMED GENTILI IRELAND LIMITED currently on record is WILLIAM SHERIDAN; five officers are currently on record for NEOPHARMED GENTILI IRELAND LIMITED, filed with Companies Registration Office (CRO). Management authority at NEOPHARMED GENTILI IRELAND LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does NEOPHARMED GENTILI IRELAND LIMITED have a parent company or subsidiaries?

NEOPHARMED GENTILI IRELAND LIMITED sits 6 levels below its ultimate parent, NEONCO SPA, registered in Italy. 7 subsidiaries are recorded beneath it, across 8 jurisdictions. Those 7 subsidiaries span Ireland, Italy, France, Switzerland, Germany, Austria, and 2 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Can Zavia monitor changes to NEOPHARMED GENTILI IRELAND LIMITED's ownership over time?

This profile reflects a point-in-time snapshot from Companies Registration Office (CRO). Zavia's monitoring API can track changes to NEOPHARMED GENTILI IRELAND LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access NEOPHARMED GENTILI IRELAND LIMITED's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Ireland, so records like NEOPHARMED GENTILI IRELAND LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Companies Registration Office (CRO) and was last synced on 24 October 2026.

This website uses cookies to improve your web experience.